Stryker Corporation has a robust track record of double-digit earnings growth and high single-digit organic revenue growth.

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

Medtech Innovator announced that it awarded the grand prize for its early-stage accelerator to AI-driven tech developer Samay ...

Employees at the 10 largest medtech employers in the world are excited about culture but are still frustrated by corporate ...

JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...

We recently published a list of 8 High Growth UK Stocks to Invest In. In this article, we are going to take a look at where ...

Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This solution is designed to enhance conference planning and ...

德克萨斯州沃斯堡 - 专注于外科和伤口护理医疗技术的Sanara MedTech Inc. (NASDAQ: SMTI)今日宣布，James "Jim" Stuckert先生已从公司董事会辞职。Stuckert先生将在离职后继续担任名誉董事。Keith Myers先生已被任命填补董事会的空缺。 Sanara执行主席兼首席执行官Ron Nixon对Stuckert先生多年来的服务和对公司发展的贡献表 ...

新泽西州新不伦瑞克市 - 强生公司（NYSE: JNJ）已完成对专门从事心力衰竭治疗的V-Wave Ltd.的收购，扩大了其MedTech部门的心血管产品组合。V-Wave的Ventura®心房间分流器，一种用于心力衰竭患者的设备，现已成为Johnson & Johnson MedTech产品线的一部分。